Predicting survival within the lung cancer histopathological hierarchy using a multi-scale genomic model of development
2006

Predicting Lung Cancer Survival Using Genomic Models

Sample size: 186 publication 10 minutes Evidence: moderate

Author Information

Author(s): Liu Hongye, Kho Alvin T, Kohane Isaac S, Sun Yao

Primary Institution: Children's Hospital Boston

Hypothesis

Can the molecular dynamics of lung development provide insights into lung cancer prognosis?

Conclusion

The study found that earlier genomic associations with mouse lung development correlate with poorer patient prognosis in lung cancer.

Supporting Evidence

  • Patients with lung cancer whose gene expression profiles were similar to early mouse lung development had poorer survival rates.
  • The study identified specific gene sets linked to lung cancer prognosis.
  • Kaplan-Meier survival analysis showed significant differences in survival based on genomic placement.

Takeaway

Researchers looked at lung cancer genes and compared them to mouse lung development to see if they could predict how patients would do. They found that if the cancer genes looked more like early mouse genes, the patients did worse.

Methodology

The study used principal component analysis to compare gene expression in lung cancer samples with mouse lung development data.

Potential Biases

Potential biases in gene expression data and patient selection.

Limitations

Further validation is needed to confirm findings across different patient groups.

Participant Demographics

186 lung cancer patients with various subtypes.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.1371/journal.pmed.0030232

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication